Lamivudine
NDC 53808-0844
Product Information
Lamivudine is a ANDA-approved product labeled by State Of Florida Doh Central Pharmacy. This drug is used with other HIV medications to help control HIV infection. It is supplied as a white product. This product entry covers the primary NDC 53808-0844 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
GRAY (C48324)
18 MM
APO;LMV;150
APO;LMV;300
1
Code Structure Chart
Product Details
What is NDC 53808-0844?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LAMIVUDINE (UNII: 2T8Q726O95)
- LAMIVUDINE (UNII: 2T8Q726O95) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- CROSPOVIDONE (UNII: 68401960MK)
- COLLOIDAL SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 199147 - lamiVUDine 150 MG Oral Tablet
- RxCUI: 199147 - lamivudine 150 MG Oral Tablet
- RxCUI: 199147 - 3TC 150 MG Oral Tablet
- RxCUI: 349491 - lamiVUDine 300 MG Oral Tablet
- RxCUI: 349491 - lamivudine 300 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.